Biological treatments for paediatric psoriasis (BiPe): A retrospective observational study on biological drug survival in daily practice in childhood psoriasis

Atopic Dermatitis

Drug survival and post-drug survival of first-line immunosuppressive treatments for atopic dermatitis: comparison between methotrexate and cyclosporine

J Eur Acad Dermatol Venereol.

Law Ping Man S, Bouzillé G, Beneton N, Safa G, Dupuy A, Droitcourt C

doi: 10.1111/jdv.14880.

Psoriasis

Drug Survival of Adalimumab, Ustekinumab, and Secukinumab in Patients with Psoriasis: a Prospective Cohort Study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)

Br J Dermatol.

Yiu ZZN, Mason KJ, Hampton PJ, Reynolds NJ, Smith CH, Lunt M, Griffiths CEM, Warren RB, BADBIR Study Group.

doi: 10.1111/bjd.18981.

Psoriasis

Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicenter study by the Spanish Psoriasis Group

J Eur Acad Dermatol Venereol.

Del Alcázar E, Suárez-Pérez JA, Armesto S, Rivera R, Herrera-Acosta E, Herranz P, Martín I, Montesinos E, Hospital M, Vilarrasa E, Ferran M, Ruiz-Villaverde R, Sahuquillo-Torralba A, Ruiz-Genao DP, Pérez-Barri S, Muñoz C, Llamas M, Valentí F, Josune Mitxelena M, López-Ferrer A, Carretero G, Vidal D, Mollet J, Belinchón I, Manuel Carrascosa J

doi: 10.1111/jdv.16439.

Psoriatic Arthritis

Long-term etanercept survival in patients with psoriatic arthritis: a multicenter retrospective analysis in daily clinical practice in Spain

Rheumatol Int.

Deza G, Notario J, Ferran M, Beltrán E, Almirall M, Alcalá R, Ruiz-Carrascosa JC, Sánchez R, Pérez S, García-Vivar ML, Galíndez E, Mora M, Rodríguez J, Gallardo F

doi: 10.1007/s00296-018-4144-8.

Further Publications Dermatology

Efficacy and safety of treatments in cutaneous polyarteritis nodosa: a French observational retrospective study

J Am Acad Dermatol

Bettuzzi T, Jachiet M, Sbidian E, Frumholtz L, Cordoliani F, Mouthon L, Chasset F, Paule R, Bouaziz JD, Guillevin L, Terrier B, Aractingi S, Dupin N, Régent A

doi: 10.1016/j.jaad.2021.06.872

Psoriasis

Ixekizumab Survival in Heavily Pretreated Patients with Psoriasis: A Two-year Single-centre Retrospective Study

Acta Derm Venereol

Sherman S, Zloczower O, Noyman Y, Amitay-Laish I, Hodak E, Pavlovsky L

doi: 10.2340/00015555-3714

Psoriasis

Drug Survival in Patients with Psoriasis is Associated with the Availability of Biologic Medications

J Eur Acad Dermatol Venereol.

Shalom G, Cohen AD, Feldhamer I, Comaneshter D, Freud T, Pavlovsky L

doi: 10.1111/jdv.16205.

Further Publications Dermatology

Survival of Adjuvant Drugs for Treatment of Pemphigus: A Population-based Cohort Study

Acta Derm Venereol

Kridin K, Hammers CM, Ludwig RJ, Tzur Bitan D, Cohen AD

doi: 10.2340/00015555-3831

Juvenile Idiopathic Arthritis

Safety of biological agents in paediatric rheumatic diseases: a real-life multicenter retrospective study using the JIRcohorte database

Joint Bone Spine.

Cabrera N, Lega JC, Kassai B, Wouters C, Kondi A, Cannizzaro E, Woerner A, Chausset A, Roethlisberger S, Jeanneret C, Aeschlimann F, Malik S, Duquesne A, Kaiser D, Higel L, Maes A, Berthet G, Hentgen V, Kone-Paut I, Belot A, Hofer M

doi: 10.1016/j.jbspin.2018.08.003.

Related content

Drug survival and post-drug survival of first-line immunosuppressive treatments for atopic dermatitis: comparison between methotrexate and cyclosporine

Drug Survival of Adalimumab, Ustekinumab, and Secukinumab in Patients with Psoriasis: a Prospective Cohort Study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)

Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicenter study by the Spanish Psoriasis Group

Long-term etanercept survival in patients with psoriatic arthritis: a multicenter retrospective analysis in daily clinical practice in Spain

Efficacy and safety of treatments in cutaneous polyarteritis nodosa: a French observational retrospective study

Ixekizumab Survival in Heavily Pretreated Patients with Psoriasis: A Two-year Single-centre Retrospective Study

Drug Survival in Patients with Psoriasis is Associated with the Availability of Biologic Medications

Survival of Adjuvant Drugs for Treatment of Pemphigus: A Population-based Cohort Study

Safety of biological agents in paediatric rheumatic diseases: a real-life multicenter retrospective study using the JIRcohorte database